Barbara O’Brien
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
Papers in
- Genetics 33
- Glioma Diagnosis and Treatment 33
-
- Brain Metastases and Treatment 29
- Co-authors
- Rivka R. Colen (2 shared papers)Marta Peñas-Prado (13 shared papers)Monica Loghin (15 shared papers)W.K. Alfred Yung (7 shared papers)Mark R. Gilbert (5 shared papers)John de Groot (11 shared papers)Charles A. Conrad (4 shared papers)Vinay K. Puduvalli (8 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Neuro-Oncology (11 papers)Journal of Neuro-Oncology (3 papers)Cancer Research (2 papers)Neuro-Oncology Advances (2 papers)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Barbara O’Brien
46 papers receiving 470 citations
Peers
Comparison fields: 5 of 69
- Genetics 239
- Oncology 180
- Pulmonary and Respiratory Medicine 170
- Cancer Research 53
- Rehabilitation 24
Countries citing papers authored by Barbara O’Brien
This map shows the geographic impact of Barbara O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara O’Brien more than expected).
Fields of papers citing papers by Barbara O’Brien
This network shows the impact of papers produced by Barbara O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara O’Brien. The network helps show where Barbara O’Brien may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 51 | |
| 2 | 2016 | 50 | |
| 3 | 2019 | 50 | |
| 4 | 2019 | 42 | |
| 5 | 2016 | 38 | |
| 6 | 2021 | 23 | |
| 7 | 2020 | 23 | |
| 8 | 2014 | 20 | |
| 9 | 2018 | 16 | |
| 10 | 2018 | 16 | |
| 11 | 2019 | 14 | |
| 12 | 2020 | 14 | |
| 13 | 2015 | 13 | |
| 14 | 2021 | 13 | |
| 15 | 2021 | 11 | |
| 16 | 2019 | 8 | |
| 17 | 2020 | 8 | |
| 18 | 2021 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2018 | 5 |
About Barbara O’Brien
Barbara O’Brien is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 56 papers that have together received 478 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (33 papers), Brain Metastases and Treatment (29 papers), Nanoplatforms for cancer theranostics (6 papers), CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Healthcare professionals’ stress and burnout (4 papers), Management of metastatic bone disease (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Genetics (239 citations), Oncology (180 citations), Pulmonary and Respiratory Medicine (170 citations), Cancer Research (53 citations) and Rehabilitation (24 citations). Barbara O’Brien has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Rivka R. Colen, Marta Peñas-Prado, Monica Loghin, W.K. Alfred Yung, Mark R. Gilbert, John de Groot, Charles A. Conrad, Vinay K. Puduvalli, Amy B. Heimberger and Sherise D. Ferguson. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Journal of Neuro-Oncology, Cancer Research and Neuro-Oncology Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.